Literature DB >> 4112644

Classification of late myopathies based on observation of 15 new cases.

G Bekény.   

Abstract

Entities:  

Mesh:

Year:  1972        PMID: 4112644     DOI: 10.1007/bf00316198

Source DB:  PubMed          Journal:  Z Neurol        ISSN: 0012-1037


× No keyword cloud information.
  35 in total

1.  [THE IMPORTANCE OF MUSCLE BIOPSY FOR THE DIAGNOSIS AND THERAPY OF CHRONIC NEUROMUSCULAR PROCESSES. I. MORPHOLOGICAL PROCESSES].

Authors:  D SEITZ
Journal:  Dtsch Z Nervenheilkd       Date:  1965-06-14

2.  Degeneration of skeletal muscle.

Authors:  D DENNY-BROWN
Journal:  Rev Can Biol       Date:  1962 Sep-Dec

3.  Thyrotoxic myopathy and polymyositis in elderly patients; differential-diagnostic viewpoints.

Authors:  H BOSTROM; R HED
Journal:  Acta Med Scand       Date:  1958-10-22

4.  Dermatomyositis and malignancy: a review of the literature.

Authors:  R C WILLIAMS
Journal:  Ann Intern Med       Date:  1959-05       Impact factor: 25.391

5.  The nature of polymyositis and related muscular diseases.

Authors:  D DENNY-BROWN
Journal:  Trans Stud Coll Physicians Phila       Date:  1960-07

6.  [Chronic polymyositis; trial with cortisone therapy].

Authors:  L VAN BOGAERT; M A RADERMECKER; A LOWENTHAL; C J KETELAER
Journal:  Acta Neurol Psychiatr Belg       Date:  1955-11

7.  Effects of cortisone in certain neuromuscular disorders.

Authors:  G M SHY; S BRENDLER; R RABINOVITCH; D McEACHERN
Journal:  J Am Med Assoc       Date:  1950-12-16

8.  Observations on Myopathy.

Authors:  E Bramwell
Journal:  Proc R Soc Med       Date:  1923

9.  Classification of the neuromuscular disorders. Appendix A to the Minutes of the Meeting of the Research Group on Neuromuscular Diseases, held in Montreal, Canada, on 21 September, 1967.

Authors: 
Journal:  J Neurol Sci       Date:  1968 Jan-Feb       Impact factor: 3.181

10.  Acid maltase deficiency in adults: studies in four cases of a syndrome which may mimic muscular dystrophy or other myopathies.

Authors:  A G Engel
Journal:  Brain       Date:  1970       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.